Literature DB >> 23604362

Diagnostic and management difficulties in a case of multiple intracranial juvenile xanthogranuloma.

Kentaro Chiba1, Yasuo Aihara, Seiichiro Eguchi, Masahiko Tanaka, Takashi Komori, Yoichi Nakazato, Yoshikazu Okada.   

Abstract

INTRODUCTION: Juvenile xanthogranuloma (JXG) preferentially occurs in childhood, and its characteristics have been thought to be benign and with slow growth. JXG is classified as an inflammatory disease, which forms multiple lesions in the patients' head, neck, and other organs and typically skin. JXG is rare, and few case reports have been published in the past, particularly with multiple intracranial lesions, which as in our case, is an extremely rare finding. CASE: Patient is a 4-year-old boy who presented with polydypsia and polyuria for 1 year. He had been followed up only under l-deamino-8-D-arginine vasopressin until he started vomiting and his level of consciousness deteriorated. Then, magnetic resonance imaging (MRI) revealed multiple intracranial lesions. He underwent biopsy via small craniotomy, and pathology was confirmed as juvenile xanthogranuloma. The patient received chemotherapy, in complete compliance with JLSG-02 protocol.
FINDINGS: JXG is characteristic with homogenous enhancement with contrast matter and, most importantly, high intensity on diffusion-weighted image (DWI). The DWI was high when the degree of diffusion of water is restricted, as seen in inflammation and, additionally, the change of intensity after administration of steroid would reflect its anti-inflammatory nature. However, though the steroid therapy made high-intensity lesions decrease signal intensity, the size and the number of lesions did not change at all. As we expected, after we stopped steroid administration to the patient, his consciousness deteriorated and we found again the very-high-intensity lesions. We consider the intensity on DWI to reflect progression of the lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604362     DOI: 10.1007/s00381-013-2100-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

Review 1.  Multiple intracranial juvenile xanthogranulomas. Case report.

Authors:  J Boström; G Janssen; M Messing-Jünger; J U Felsberg; E Neuen-Jacob; V Engelbrecht; H G Lenard; W J Bock; G Reifenberger
Journal:  J Neurosurg       Date:  2000-08       Impact factor: 5.115

2.  The role of lymphocytes and monocytes in hematopoietic growth factor production by peripheral blood mononuclear cells.

Authors:  K Kaushansky; J E Miller; D R Morris; C B Wilson; W P Hammond
Journal:  Cell Immunol       Date:  1989-08       Impact factor: 4.868

3.  Incidental pediatric intraparenchymal xanthogranuloma: case report and review of the literature.

Authors:  William W Ashley; Prithvi Narayan; Tae Sung Park; Pang-hsien Tu; Arie Perry; Jeffrey R Leonard
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

4.  Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163.

Authors:  Jeffrey A Vos; Susan L Abbondanzo; Carol L Barekman; Joann W Andriko; Markku Miettinen; Nadine S Aguilera
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

5.  Intracranial non-Langerhans cell histiocytosis presenting as an isolated intraparenchymal lesion.

Authors:  Smitha Rajaram; Stephen B Wharton; Fiona Shackley; Ashok Raghavan; Daniel J A Connolly
Journal:  Pediatr Radiol       Date:  2010-07-16

Review 6.  Multicentric parenchymal xanthogranuloma in a child: case report and review of the literature.

Authors:  Maciej S Lesniak; Michael P Viglione; Jon Weingart
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

7.  Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system.

Authors:  Regina Dölken; Steffen Weigel; Henry Schröder; Maite Hartwig; Dieter Harms; James F Beck
Journal:  J Pediatr Hematol Oncol       Date:  2006-02       Impact factor: 1.289

8.  Central nervous system juvenile xanthogranuloma with malignant transformation.

Authors:  Andrea Orsey; Michele Paessler; Beverly J Lange; Kim E Nichols
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

9.  Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.

Authors:  Takuya Nakatani; Akira Morimoto; Ryuichi Kato; Sachiko Tokuda; Tohru Sugimoto; Kazuaki Tokiwa; Yasunari Tsuchihashi; Shinsaku Imashuku
Journal:  J Pediatr Hematol Oncol       Date:  2004-06       Impact factor: 1.289

10.  Intracranial solitary juvenile xanthogranuloma successfully treated with stereotactic radiosurgery.

Authors:  Satoshi Nakasu; Atsushi Tsuji; Ikuko Fuse; Hisao Hirai
Journal:  J Neurooncol       Date:  2007-02-27       Impact factor: 4.506

View more
  4 in total

1.  Multimodel MRI features of an intracranial juvenile Xanthogranuloma.

Authors:  Jingkai Su; Ni Chen; Qiang Yue; Weina Wang; Simin Zhang; Xiaorui Su
Journal:  Childs Nerv Syst       Date:  2019-02-28       Impact factor: 1.475

Review 2.  Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.

Authors:  Sherise D Ferguson; Steven G Waguespack; Lauren A Langford; Joann L Ater; Ian E McCutcheon
Journal:  Childs Nerv Syst       Date:  2014-12-12       Impact factor: 1.475

3.  Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck.

Authors:  D T Ginat; S O Vargas; V M Silvera; M S Volk; B A Degar; C D Robson
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

Review 4.  Aggressive surgical management of recurrent intracranial juvenile xanthogranuloma: case report and review of the literature.

Authors:  Salman AlQazlan; Abdulrahman Albakr; Abdullah Al Towim; Yazeed Alsaadan; Hamdy Hassan; Khaldoon Aljerian; Sherif Elwatidy
Journal:  Childs Nerv Syst       Date:  2019-08-05       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.